Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

Name: Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
License: Public Domain

AdventHealth

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic cancer, urothelial carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 195303
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.